Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

72580 result(s) found, displaying 29701 to 29725

APO-GLIMEPIRIDE glimepiride 1mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
APO-GLIMEPIRIDE glimepiride 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
APO-GLIMEPIRIDE glimepiride 3mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
APO-GLIMEPIRIDE glimepiride 4mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
APO-INDAPAMIDE indapamide hemihydrate 2.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-LERCANIDIPINE lercanidipine hydrochloride 10 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-LERCANIDIPINE lercanidipine hydrochloride 20 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-MEROPENEM meropenem (as trihydrate) 500 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-RALOXIFENE raloxifene hydrochloride 60 mg tablet blister Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-RALOXIFENE raloxifene hydrochloride 60 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-RAMIPRIL ramipril 1.25mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-RAMIPRIL ramipril 2.5mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-RAMIPRIL ramipril 5mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Telmisartan HCTZ 80/12.5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
Apotex Pty Ltd - Earwax softening otic solution Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PANTOPRAZOLE pantoprazole (as sodium sesquihydrate) 20 mg enteric coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PANTOPRAZOLE pantoprazole (as sodium sesquihydrate) 40 mg enteric coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-TRANDOLAPRIL trandolapril 1 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-TRANDOLAPRIL trandolapril 2 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-TRANDOLAPRIL trandolapril 4 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-VALSARTAN HCTZ 160/12.5 valsartan and hydrochlorothiazide160/12.5 mg tablet blisters Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Valsartan HCTZ 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-VALSARTAN HCTZ 320/25 valsartan and hydrochlorothiazide 320/25 mg tablet blisters Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Valsartan HCTZ 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-VALSARTAN valsartan 160 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

APO-GLIMEPIRIDE glimepiride 1mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-GLIMEPIRIDE glimepiride 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-GLIMEPIRIDE glimepiride 3mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-GLIMEPIRIDE glimepiride 4mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-INDAPAMIDE indapamide hemihydrate 2.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-LERCANIDIPINE lercanidipine hydrochloride 10 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-LERCANIDIPINE lercanidipine hydrochloride 20 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-MEROPENEM meropenem (as trihydrate) 500 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

APO-RALOXIFENE raloxifene hydrochloride 60 mg tablet blister Cancelled under Section 30(1)(c) of the Act

APO-RALOXIFENE raloxifene hydrochloride 60 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

APO-RAMIPRIL ramipril 1.25mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

APO-RAMIPRIL ramipril 2.5mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

APO-RAMIPRIL ramipril 5mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

APO-Telmisartan HCTZ 80/12.5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

Apotex Pty Ltd - Earwax softening otic solution Cancelled under Section 41GL(d) of the Act

APOTEX-PANTOPRAZOLE pantoprazole (as sodium sesquihydrate) 20 mg enteric coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

APOTEX-PANTOPRAZOLE pantoprazole (as sodium sesquihydrate) 40 mg enteric coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

APO-TRANDOLAPRIL trandolapril 1 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

APO-TRANDOLAPRIL trandolapril 2 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

APO-TRANDOLAPRIL trandolapril 4 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

APO-VALSARTAN HCTZ 160/12.5 valsartan and hydrochlorothiazide160/12.5 mg tablet blisters Cancelled under Section 30(1)(c) of the Act

APO-Valsartan HCTZ 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-VALSARTAN HCTZ 320/25 valsartan and hydrochlorothiazide 320/25 mg tablet blisters Cancelled under Section 30(1)(c) of the Act

APO-Valsartan HCTZ 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-VALSARTAN valsartan 160 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?